Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Inside the messy middle of January Digital agency’s AI adoption
Brands and their agency partners have started using agents to plan, execute, and optimize ad purchases.
Walmart goes global with its Amazon-like flywheel
Walmart executives are beginning to take a more international approach to growing the retailer’s higher-margin businesses.
Brands are catching World Cup fever even without official sponsorships
Some smaller U.S. startups, like Crumbl Cookies and Olipop, are getting into the spirit of the World Cup with watch parties and soccer-themed products.